Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis

Blood. 2007 Jul 15;110(2):787-8. doi: 10.1182/blood-2007-02-076034.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloidosis / drug therapy*
  • Amyloidosis / immunology*
  • Amyloidosis / mortality
  • Amyloidosis / therapy
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Combined Modality Therapy
  • Dexamethasone / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Immunoglobulin Light Chains
  • Melphalan / therapeutic use*
  • Stem Cell Transplantation*
  • Survival Analysis
  • Survivors
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents, Alkylating
  • Immunoglobulin Light Chains
  • Dexamethasone
  • Melphalan